Sangui Biotech International, Inc.
SGBI · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $133 | $93 | $69 | $66 |
| % Growth | 43.3% | 34.5% | 5.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $133 | $93 | $69 | $66 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $5 | $9 | $8 |
| G&A Expenses | $135 | $176 | $199 | $208 |
| SG&A Expenses | $135 | $176 | $199 | $208 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | $1 |
| Operating Expenses | $135 | $181 | $209 | $217 |
| Operating Income | -$2 | -$88 | -$139 | -$151 |
| % Margin | -1.3% | -94.7% | -201.5% | -230.4% |
| Other Income/Exp. Net | -$6 | -$60 | $76 | -$53 |
| Pre-Tax Income | -$8 | -$148 | -$63 | -$199 |
| Tax Expense | $0 | $0 | $0 | $32 |
| Net Income | -$12 | -$148 | -$59 | -$236 |
| % Margin | -9.1% | -158.8% | -85.7% | -359.8% |
| EPS | -0 | -0.001 | -0 | -0.001 |
| % Growth | 85.7% | -133.3% | 75% | – |
| EPS Diluted | -0 | -0.001 | -0 | -0.001 |
| Weighted Avg Shares Out | 212,982 | 210,129 | 208,605 | 204,192 |
| Weighted Avg Shares Out Dil | 209,956 | 209,956 | 208,605 | 204,192 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $20 | $0 | $19 | $18 |
| Depreciation & Amortization | $0 | $0 | $22 | $1 |
| EBITDA | -$1 | -$88 | -$22 | -$165 |
| % Margin | -1.1% | -94.3% | -32.5% | -252% |